Ildiko Csiki

Dr. Ildiko Csiki is a highly qualified medical professional with a diverse educational background and extensive experience in various healthcare and research organizations.

She obtained her Doctor of Medicine (M.D.) degree in Medicine from Vanderbilt University School of Medicine, where she also completed a Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology. Dr. Csiki holds a Bachelor of Science (B.S.) in Biology/Chemistry, Magna cum Laude from the University of Arkansas at Fayetteville, and a Bachelor of Arts (B.A.) in Psychology from the same institution.

In addition to her medical and scientific education, Dr. Csiki has furthered her knowledge by studying General Management at The Wharton School.

Dr. Csiki has held several key positions in prestigious organizations, currently serving as the Chief Commercial R&D Officer at City of Hope. Her past roles include Chief Medical Officer at Sensei Bio, Vice President Clinical Development Immuno-Oncology at Inovio Pharmaceuticals Inc., Senior Medical Director/Clinical Lead, Immuno-Oncology Clinical Research at Merck, Director Clinical Development, Oncology, R&D at GSK.

She also has experience in academia, having served as an Assistant Professor of Radiation Oncology at Penn Medicine, University of Pennsylvania Health System. Dr. Csiki has a background in palliative care and radiation oncology, with previous roles as a Palliative Care Physician at Alive Hospice and a Radiation Oncologist at the Department of Radiation Oncology, Vanderbilt University Medical Center.

Dr. Csiki began her career as an Internal Medicine Resident and later as a Postdoctoral Fellow at the Department of Radiation Oncology, Vanderbilt University Medical Center.